Chapter 7: Pharmaceutical Pricing and Reimbursement in Canada

Pharmaceutical pricing and reimbursement in Canada Canada is the world's eighth largest pharmaceutical market (after the United States, Japan, Germany, France, the United Kingdom, Italy, and Spain). In 2004, according to IMS Health, pharmaceutical sales in Canada totaled US $10 billion (at ex-manufacturer prices), equivalent to 2.9% of total sales in major world markets. Canada's market share has been rising steadily, reflecting sales growth that has outpaced that of other markets. In 2004, Canada's pharmaceutical sales grew 9% (in local currency terms), while sales grew 8% in the United States, 7% in the United Kingdom and Spain, 5% in France, 3% in Italy, and 1% in Germany. The Canadian Institute for Health Information (CIHI) estimates that the total expenditure for prescription and nonprescription drugs in 2004 was C$21.8 billion (US $16.7 billion), up from C$18.4 billion (US $14.1 billion) in 2002. (The US-to-Canadian dollar exchange rate used in this report ...

Users without subscription are not able to see the full content on this title. Please, subscribe or login to access all content on this website.

• Buy The Book